
September 16, 1997
Petitioners Introduction The petition filed today charges the Environmental Protection Agency with the wanton destruction of the of the world's most important biological pesticide. The natural toxins produced by a bacterium called Bacillus thuringiensis (B.t), are essential to a 21st century agriculture based on biological controls and not the use of synthetic insecticides. B.t. is a vital component in organic farming and in the international effort to reduce the environmental and human health impacts of the use chemical pesticides. Bt's effectiveness is based on its production of a number of insect toxins. When certain insects ingest the toxin proteins produced by the bacterium, the function of their digestive system is disrupted and the insects die. Bthas been registered as a spray pesticide with the EPA since 1961. Bt is used widely in sprays to kill agricultural pests and those which destroy trees. Bt toxin has been hailed as a perfect pesticide because it can specifically target certain pests without having a detrimental effect on mammals, birds or non-target insect species and microorganisms. Bt sprays leave no poisonous residue on crops or trees and are readily degraded in the environment.Bt pesticides used in foliar spray are critical for many organic farming programs and have been identified by the EPA as a safer pest control method than chemical pesticide alternatives. The agency has further recognized that Bt pesticides have low dietary, worker, and ecological risks when compared to the more hazardous alternatives that might replace Bt pesticide should resistance develop. Bt pesticides sales in the United States today amount to $60 million annually and account for the biggest share of biopesticide sales. The Bt pesticides also are important in many Integrated Pest Management (IPM) programs for a variety of crops. Because of its effectiveness and safety of Bt compared to the pesticides it displaces, Bt is probably the single most important insecticide ever discovered and the loss of such a pesticide would cause growers to switch to more harmful synthetic pesticides. If exposed to continuous, massive doses of Bt, insects can develop resistance to the biopesticide. Since 1981, the EPA has been on notice that resistance to Bt has developed in certain pests. A centralpriority for all those interested in organic, sustainable agriculture and forest protection is to minimize all potential for further development of Bt resistance. Genetically Engineered Bt Plants For many years researchers and corporations have experimented with genetically engineering Bt toxins into the permanent genetic code of plants. The first of these "transgenic" Bt plants was field tested in 1986 in the US and France. As of 1997, more than 600 field trials have been conducted world wide. In the US Bt transgenic crops occupy more than 3 million acres. In early 1995 EPA began the limited FIFRA registration of these "transgenic" Bt plant pesticides for plant propagation. Registration of these plant pesticides for use in interstate commerce soon followed. As of 1997, more than twenty were approved or pending approval world- wide. Numerous companies such as Monsanto, Novartis, Pioneer, and AgrEvo have already begun commercialization of transgenic Bt plants. In granting approval for transgenic Bt plants EPA has failed to address the potentially devastating environmental impacts of these genetically engineered plants. These include:
Conclusion The EPA has ignored the potential adverse environmental and economic impacts of registering transgenic Bt plants. The use of these plants threatens a valuable, non-toxic and biodegradable pesticide that could be lost forever. This would be a devastating blow to sustainable agriculture, IPM efforts, and organic farmers especially. It would also result in significant increase in the use of chemical pesticides with their attendant environmental and human health impacts. Therefore petitioners request that EPA:
Petitioners are expecting a substantive response to their petition within ninety (90) days. In the absence of an affirmative response, petitioners will have exhausted their administrative remedies and will filelitigation in order to achieve the agency actions requested.
|
|
|
Last Updated on 5/7/99 By Karen Lutz Email: karen@biotech-info.net |
|